SCHEMBL14099252

SCHEMBL14099252

c1cncc(N(c2cccnc2)c2ccc(N(c3cccnc3)c3cccnc3)c3nc4c(nc23)-c2cccc3cccc-4c23)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
MAPK1 P28482 3/20 0.41
HSD17B10 Q99714 2/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 6/20 0.39
ATM Q13315 2/20 0.39
UBE2N P61088 1/20 0.39
RAB9A P51151 3/20 0.33
MEN1 O00255 2/20 0.33
RECQL P46063 2/20 0.33
KMT2A Q03164 2/20 0.33
MCL1 Q07820 2/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
PSMD14 O00487 2/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 7/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14492008 0.85 ALDH1A1 (0.40) MAPTMAPK1HSD17B10GAAHTT
SCHEMBL14099425 0.84 ALDH1A1 (0.41) MAPTMAPK1HSD17B10GAAKDM4E
SCHEMBL14374565 0.82 ALDH1A1 (0.38) MAPTMAPK1HSD17B10GAAKDM4E
SCHEMBL14492020 0.78 ALDH1A1 (0.35) MAPK1HSD17B10ATMMCL1ALDH1A1
SCHEMBL14099370 0.78 ALDH1A1 (0.34) MAPTMAPK1HSD17B10GAAKDM4E
SCHEMBL14492021 0.78 ALDH1A1 (0.35) MAPK1HSD17B10ATMMCL1ALDH1A1
SCHEMBL14099382 0.78 ALDH1A1 (0.39) MAPTMAPK1HSD17B10GAAKDM4E
SCHEMBL14492016 0.77 ALDH1A1 (0.36) MAPTMAPK1HSD17B10GAAKDM4E
SCHEMBL14491996 0.76 ALDH1A1 (0.38) MAPK1HSD17B10KDM4EATMALDH1A1
SCHEMBL14099424 0.76 ALDH1A1 (0.38) MAPK1HSD17B10KDM4EATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1956011-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2008-08-13 EP disclosed
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-14 US disclosed
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME KCNH2, SLC7A5, KCNH3 MAPT 1443/4885MAPK1 862/4885HSD17B10 2301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.